Dtsch Med Wochenschr 2009; 134(36): 1745-1754
DOI: 10.1055/s-0029-1234010
CME-Beitrag | Review article
Rheumatologie
© Georg Thieme Verlag KG Stuttgart · New York

Rheumatoide Arthritis

Rheumatoid arthritisM. Wahle1
  • 1Schwerpunkt Rheumatologie, Medizinische Klinik II, Klinikum der Johann Wolfgang von Goethe-Universität Frankfurt
Further Information

Publication History

eingereicht: 23.5.2009

akzeptiert: 23.7.2009

Publication Date:
28 August 2009 (online)

Literatur

  • 1 Aletaha D, Huizinga T W. The use of data from early arthritis clinics for clinical research.  Best Pract Res Clin Rheumatol. 2009;  23 117-123
  • 2 Arnett F C, Edworthy S M, Bloch D A. et al . The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.  Arthritis Rheum. 1988;  31 315-324
  • 3 Bang H, Egerer K, Gauliard A. et al . Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.  Arthritis Rheum. 2007;  56 2503-2511
  • 4 Bowes J, Barton A. Recent advances in the genetics of RA susceptibility.  Rheumatology (Oxford). 2008;  47 399-402
  • 5 Braun J, Kastner P, Flaxenberg P. et al . Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial.  Arthritis Rheum. 2008;  58 73-81
  • 6 Choy E H, Panayi G S. Cytokine pathways and joint inflammation in rheumatoid arthritis.  N Engl J Med. 2001;  344 907-916
  • 7 Goekoop-Ruiterman Y P, de Vries-Bouwstra J K, Allaart C F. et al . Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.  Arthritis Rheum. 2005;  52 3381-3390
  • 8 Gregersen P K, Silver J, Winchester R J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis.  Arthritis Rheum. 1987;  30 1205-1213
  • 9 Hutchinson D, Shepstone L, Moots R, Lear J T, Lynch M P. Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA.  Ann Rheum Dis. 2001;  60 223-227
  • 10 Kirwan J R. Links between radiological change, disability, and pathology in rheumatoid arthritis.  J Rheumatol. 2001;  28 881-886
  • 11 Klareskog L, Ronnelid J, Lundberg K, Padyukov L, Alfredsson L. Immunity to citrullinated proteins in rheumatoid arthritis.  Annu Rev Immunol. 2008;  26 651-675
  • 12 Malysheva O A, Wahle M, Wagner U. et al . Low-dose prednisolone in rheumatoid arthritis: adverse effects of various disease modifying antirheumatic drugs.  J Rheumatol. 2008;  35 979-985
  • 13 Nielen M M, van Schaardenburg D, Reesink H W. et al . Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors.  Arthritis Rheum. 2004;  50 380-386
  • 14 Ostergaard M, Pedersen S J, Dohn U M. Imaging in rheumatoid arthritis – status and recent advances for magnetic resonance imaging, ultrasonography, computed tomography and conventional radiography.  Best Pract Res Clin Rheumatol. 2008;  22 1019-1044
  • 15 Prevoo M L, van’t Hof M A, Kuper H H. et al . Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.  Arthritis Rheum. 1995;  38 44-48
  • 16 Riccio A, Conca P, Marzocchella C, Tarantino G. Rheumatoid factor after antiviral therapy in patients with HCV chronic hepatitis.  Clin Exp Rheumatol. 2008;  26 926-928
  • 17 Saraux A, Berthelot J M, Chales G. et al . Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later.  Arthritis Rheum. 2001;  44 2485-2491
  • 18 Scheel A K, Hermann K G, Kahler E. et al . A novel ultrasonographic synovitis scoring system suitable for analyzing finger joint inflammation in rheumatoid arthritis.  Arthritis Rheum. 2005;  52 733-743
  • 19 Sigurdsson S, Padyukov L, Kurreeman F A. et al . Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis.  Arthritis Rheum. 2007;  56 2202-2210
  • 20 Symmons D P. Looking back: rheumatoid arthritis – aetiology, occurrence and mortality.  Rheumatology (Oxford). 2005;  44 Suppl 4 iv14-iv17
  • 21 Symmons D P, Silman A J. Aspects of early arthritis. What determines the evolution of early undifferentiated arthritis and rheumatoid arthritis? An update from the Norfolk Arthritis Register.  Arthritis Res Ther. 2006;  8 214
  • 22 van der Heijde D M, van Leeuwen M A, van Riel P L, van de Putte L B. Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp’s method (van der Heijde modification).  J Rheumatol. 1995;  22 1792-1796
  • 23 van der Helm-van Mil A H, le Cessie S, van Dongen H. et al . A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions.  Arthritis Rheum. 2007;  56 433-440
  • 24 van Dongen H, van Aken J, Lard L R. et al . Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial.  Arthritis Rheum. 2007;  56 1424-1432
  • 25 Visser H. Early diagnosis of rheumatoid arthritis.  Best Pract Res Clin Rheumatol. 2005;  19 55-72
  • 26 Vital E M, Emery P. The development of targeted therapies in rheumatoid arthritis.  J Autoimmun. 2008;  31 219-227
  • 27 Wassenberg S, Rau R, Steinfeld P, Zeidler H. Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial.  Arthritis Rheum. 2005;  52 3371-3380
  • 28 Wollenhaupt J, Alten R, Backhaus M, Baerwald C, Braun J, Burkhardt H, Gaubitz M, Gromnica-Ihle E, Kellner H, Kuiper J, Lorenz H M, Manger B, Müller-Ladner U, Nüßlein H G, Pott H G, Rubbert-Roth A, Schneider M, Specker C, Tony H P, Krüger K. Aktualisiertes Therapieschema der Rheumatoiden Arthritis. Ergebnisse eines Konsensusprozesses deutscher Rheumatologen 2009.  Akt Rheum. 2009;  34 , epub 7.5.2009, DOI: 10.1055/s-0029-1220906

PD Dr. med. Matthias Wahle

Klinikum der JW Goethe-Universität Frankfurt am Main, Schwerpunkt Rheumatologie, Medizinische Klinik II

Theodor-Stern-Kai 7

60590 Frankfurt am Main

Phone: +49-69-6301 7301

Fax: +49-69-6301 7307

Email: matthias.wahle@kgu.de

    >